MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Modulation of pallidal activity by circadian rhythms: a new variable to be accounted for closed-loop DBS?

    T. de Araujo, J. Cagle, F. Sarmento, K. Johnson, L. Almeida, C. de Hemptinne (Gainesville, USA)

    Objective: To analyze the influence of circadian rhythmson local field potentials (LFPs) recorded in the Globus Pallidus Internal (GPi) of patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    Olfactory discrimination differentiate drug-induced parkinsonism and Parkinson’s disease

    IH. Kwak, JJ. Lee, MS. Kim, SY. Kang, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

    Objective: In this study, we evaluated detailed differential features of olfactory function in PD and DIP. Background: DIP is common but it is challenging to…
  • 2023 International Congress

    Dietary protein redistribution influences the efficacy of levodopa/carbidopa intestinal gel (LCIG) infusion

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To compare levodopa/carbidopa intestinal gel (LCIG) with equally distributed dietary protein (Diet_EDP) versus restricted to twice daily (Diet_RP) and Mediterranean diet (Diet_M). Background: Levodopa…
  • 2023 International Congress

    Pupil response is impaired in clinically isolated REM Sleep Behavior Disorder and Parkinsons’ Disease

    W. Hermann, M. Brandt, T. Sehr, U. Walter, H. Reichmann, A. Storch, T. Ziemssen (Rostock, Germany)

    Objective: Since easily accessible (bio-) markers are needed to predict progression and outcome in prodromal stages of neurodegenerative diseases this study was designed to evaluate…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Use of stimview technology in deep brain stimulation of Parkinson´s disease patients

    A. Rodríguez-Sanz, S. Serrano López, B. Mansilla, M. Román, JF. Paz (Madrid, Spain)

    Objective: We present our experience of Stimview technology in the neurostimulation of 5 patients with Parkinson´s disease (PD). Background: It is common to make adjustments…
  • 2023 International Congress

    Parkinson’s disease (PD) progression is associated with past exposure to organic contaminants in water at Marine Corps Base Camp Lejeune

    S. Goldman, F. Weaver, B. Gonzalez, K. Stroupe, L. Cao, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To test whether PD progression is more rapid in individuals who were exposed to volatile organic compounds in the water supply at Camp Lejeune…
  • 2023 International Congress

    Hypnosis for Deep Brain Stimulator Surgery

    I. Cohen, D. Englert, M. Henegar, J. Rayner, K. Gamble, S. Patel (Charlotte, USA)

    Objective: To describe the use of hypnosis as an adjunct to local anesthetic during placement of deep brain stimulator (DBS) Background: DBS has become commonplace…
  • 2023 International Congress

    Foslevodopa/foscarbidopa subcutaneous infusion shows similar infusion site reaction severity score across range of infusion rates in patients with Parkinson’s disease

    L. Schlachter, S. Stodtmann, S. Talapala, M. Facheris, M. Rosebraugh (Ludwigshafen, Germany)

    Objective: Characterize the relationship between foslevodopa/foscarbidopa infusion rate and infusion site reaction (ISR) score in patients with Parkinson’s disease (PD) Background: As PD progresses, motor…
  • 2023 International Congress

    Neuromelanin related 7T MRI of the locus coeruleus differs between Parkinson’s disease and controls

    A. Wolters, M. Heijmans, N. Priovoulos, H. Jacobs, A. Postma, Y. Temel, M. Kuijf, S. Michielse (Maastricht, Netherlands)

    Objective: To compare the signal intensity of the substantia nigra and locus coeruleus on Magnetization Transfer 7T MRI between PD patients and healthy controls (HC)…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley